Founder of ASX-listed artificial intelligence data analytics startup Opyl, Michelle Gallaher, said she was "delighted" to see governments prioritising data when planning lockdown policies.Opyl has been developing an artificial intelligence tool for predicting whether a drug or vaccine is likely to succeed in a clinical trial, and the company has recently started to apply this tool to COVID-19 treatment projects.
https://www.theage.com.au/business/companies/biotechs-seek-data-crunching-role-amid-wait-for-covid-19-vaccine-20200916-p55w78.html
AFR article, page-15
Add OPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.731M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1712064 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 580887 | 2 |
View Market Depth
| Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
| OPL (ASX) Chart |
Day chart unavailable